Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia

31Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Chronic neutropenia comprises several different diseases that vary in degree of severity and management. We analysed the levels of the neutrophil-derived protein pro-LL-37 in plasma of patients with chronic neutropenia to assess whether it could be used to differentiate different categories of chronic neutropenia. All patients with severe congenital neutropenia were pro-LL-37 deficient. This was in contrast to patients with autoimmune or idiopathic neutropenia, who exhibited normal pro-LL-37 levels while patients with cyclic neutropenia displayed an oscillation of pro-LL-37 in plasma. Plasma levels of pro-LL-37 may thus prove useful for differential diagnosis of chronic neutropenia. © 2007 The Authors.

Cite

CITATION STYLE

APA

Karlsson, J., Carlsson, G., Ramme, K. G., Hägglund, H., Fadeel, B., Nordenskjöld, M., … Andersson, M. (2007). Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia. British Journal of Haematology, 137(2), 166–169. https://doi.org/10.1111/j.1365-2141.2007.06530.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free